Annual Working Capital
$228.42 M
-$14.59 M-6.00%
31 December 2023
Summary:
C4 Therapeutics annual working capital is currently $228.42 million, with the most recent change of -$14.59 million (-6.00%) on 31 December 2023. During the last 3 years, it has fallen by -$108.73 million (-32.25%). CCCC annual working capital is now -32.25% below its all-time high of $337.16 million, reached on 31 December 2020.CCCC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$229.94 M
+$8.09 M+3.65%
30 September 2024
Summary:
C4 Therapeutics quarterly working capital is currently $229.94 million, with the most recent change of +$8.09 million (+3.65%) on 30 September 2024. Over the past year, it has increased by +$36.52 million (+18.88%). CCCC quarterly working capital is now -46.95% below its all-time high of $433.39 million, reached on 30 June 2021.CCCC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | +18.9% |
| 3 y3 years | -32.3% | -36.8% |
| 5 y5 years | +129.4% | - |
CCCC Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.3% | at low | -36.8% | +18.9% |
| 5 y | 5 years | -32.3% | +261.9% | -47.0% | +264.3% |
| alltime | all time | -32.3% | +261.9% | -47.0% | +264.3% |
C4 Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $229.94 M(+3.6%) |
| June 2024 | - | $221.84 M(-1.2%) |
| Mar 2024 | - | $224.57 M(-1.7%) |
| Dec 2023 | $228.42 M(-6.0%) | $228.42 M(+18.1%) |
| Sept 2023 | - | $193.41 M(-14.5%) |
| June 2023 | - | $226.15 M(-5.4%) |
| Mar 2023 | - | $239.07 M(-1.6%) |
| Dec 2022 | $243.01 M | $243.01 M(-13.3%) |
| Sept 2022 | - | $280.19 M(+2.9%) |
| June 2022 | - | $272.22 M(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $255.96 M(-6.7%) |
| Dec 2021 | $274.44 M(-18.6%) | $274.44 M(-24.5%) |
| Sept 2021 | - | $363.61 M(-16.1%) |
| June 2021 | - | $433.39 M(+52.4%) |
| Mar 2021 | - | $284.36 M(-15.7%) |
| Dec 2020 | $337.16 M(+434.1%) | $337.16 M(+99.6%) |
| Sept 2020 | - | $168.91 M(-12.4%) |
| June 2020 | - | $192.80 M(+205.4%) |
| Dec 2019 | $63.13 M(-36.6%) | $63.13 M |
| Dec 2018 | $99.58 M | - |
FAQ
- What is C4 Therapeutics annual working capital?
- What is the all time high annual working capital for C4 Therapeutics?
- What is C4 Therapeutics annual working capital year-on-year change?
- What is C4 Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for C4 Therapeutics?
- What is C4 Therapeutics quarterly working capital year-on-year change?
What is C4 Therapeutics annual working capital?
The current annual working capital of CCCC is $228.42 M
What is the all time high annual working capital for C4 Therapeutics?
C4 Therapeutics all-time high annual working capital is $337.16 M
What is C4 Therapeutics annual working capital year-on-year change?
Over the past year, CCCC annual working capital has changed by -$14.59 M (-6.00%)
What is C4 Therapeutics quarterly working capital?
The current quarterly working capital of CCCC is $229.94 M
What is the all time high quarterly working capital for C4 Therapeutics?
C4 Therapeutics all-time high quarterly working capital is $433.39 M
What is C4 Therapeutics quarterly working capital year-on-year change?
Over the past year, CCCC quarterly working capital has changed by +$36.52 M (+18.88%)